Glaucoma News

A progression report provided comparable predictions for the risk of fast visual field progression in patients with open-angle glaucoma, according to a retrospective multicenter study published in the Journal of Glaucoma.

Glaucoma medications free of preservatives, such as benzalkonium chloride, may significantly reduce toxicity-related ocular surface disease, according to findings published in The Clinical Ophthalmologist Journal.

ATLANTA — Harry A. Quigley, MD, led a special session on glaucoma at this year’s SECO meeting that ranged from “what do we really know about glaucoma” to how glaucoma is treated with surgery and lasers.

The 2020 Optometry’s Meeting, originally scheduled for June 24 to 28 in Washington, D.C., has been canceled as part of the organization’s commitment to prioritize the health and safety of members, staff and attendees along with their families and patients, according to an announcement from American Optometric Association president Barbara L. Horn, OD, and American Optometric Student Association presidentelect Alex J. Bennett.

China’s National Medical Products Administration approved the use of the Xen gel stent for the surgical management of patients with refractory glaucoma, according to an Allergan press release.

KOLOA, Hawaii — At Hawaiian Eye 2020, Savak “Sev” Teymoorian, MD, MBA, of Harvard Eye Associates in Laguna Hills, California, discusses best current practices for the use of microstents during cataract surgery for the treatment of glaucoma.

In the past 20 years, a number of new tonometers have become available. With several of these new alternatives, the benefits offered have mostly related to portability and convenience.

Two-thirds of eyes with childhood glaucomas that underwent ab interno trabeculotomy with the Trab360 device experienced postoperative IOP of 24 mm Hg or less with no additional surgeries, according to a study.

Researchers observed a link between office-hour IOP and peak nocturnal IOP in a group of patients with primary open angle glaucoma and ocular hypertension, according to a study published in the American Journal of Ophthalmology.

Jason Bacharach, MD, medical director and founding partner at North Bay Eye Associates in the San Francisco Bay area, discusses how he has adjusted the way he treats his patients with glaucoma during the COVID-19 pandemic. From instituting three layers of separation between himself and patients he sees, while also looking to incorporate telemedicine and adjusting therapeutic prescriptions for patients, the pandemic has completely altered the way he practices.